Edition:
United States

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

118.94USD
23 Feb 2017
Change (% chg)

-- (--)
Prev Close
$118.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,516
52-wk High
$152.30
52-wk Low
$92.28

TARO.N

Chart for TARO.N

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $4,880.37
Shares Outstanding(Mil.): 41.03
Dividend: --
Yield (%): --

Financials

  TARO.N Industry Sector
P/E (TTM): 10.17 28.90 29.71
EPS (TTM): 11.69 -- --
ROI: 25.91 13.43 12.94
ROE: 25.96 14.33 14.09

India's Sun Pharma Q3 profit falls nearly 5 pct; below estimates

MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.

Feb 14 2017

BRIEF-Taro posts quarterly sales of $220.4 million

* Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42 Source text for Eikon: Further company coverage:

Feb 09 2017

BRIEF-Taro Pharmaceutical Industries names Uday Baldota CEO

* Taro Pharmaceutical Industries Ltd- Uday Baldota as chief executive officer

Nov 22 2016

BRIEF-Taro Pharmaceutical Industries qtrly loss per share $0.00

* Taro Pharmaceutical Industries Ltd - qtrly loss per share $0.00

Nov 08 2016

BRIEF-Taro appoints new chief financial officer

* Appointment of Mariano Balaguer as vice president, CFO and chief accounting officer, effective today Source text for Eikon: Further company coverage:

Oct 03 2016

U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 12 2016

U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 11 2016

UPDATE 1-U.S. Justice Department subpoenas Taro over generic drug pricing

WASHINGTON, Sept 11 Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.

Sep 11 2016

More From Around the Web

Earnings vs. Estimates